IndraLab
Statements
Lipopolysaccharide inhibits TBK1. 4 / 4
|
4
reach
"Notably, H-151 (Figure 1) is a novel selective inhibitor of STING that has been demonstrated to irreversibly reduce type I interferon response, inhibit TBK1 phosphorylation, and inhibit STING Cys91 palmitoylation, thereby suppressing downstream signaling activation [12], thereby suppressing downstream signal activation.The aim of this study was to investigate the activation of the STING–TBK1 pathway in lipopolysaccharide-induced AKI and the protective effects of H-151 in inhibiting the activation of STING–TBK1 and its impact on renal function.3."